These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7680946)

  • 21. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory infusion of bleomycin in patients receiving chemotherapy for germ cell tumors.
    Green JA; Hammond P; Watkin SW
    Sel Cancer Ther; 1989; 5(2):93-5. PubMed ID: 2475900
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 24. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
    Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH
    Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
    Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
    Brada M; Horwich A; Peckham MJ
    Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
    Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
    Kawai K; Hinotsu S; Tomobe M; Akaza H
    Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
    Einhorn LH; Foster RS
    J Clin Oncol; 2006 Jun; 24(16):2597-8; author reply 2598-9. PubMed ID: 16735718
    [No Abstract]   [Full Text] [Related]  

  • 31. Bleomycin lung: the effect of different chemotherapeutic regimens.
    Chisholm RA; Dixon AK; Williams MV; Oliver RT
    Cancer Chemother Pharmacol; 1992; 30(2):158-60. PubMed ID: 1376217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
    Curigliano G; Spitaleri G; Magni E; Lorizzo K; De Cobelli O; Locatelli M; Fumagalli L; Adamoli L; Cossu Rocca M; Verri E; De Pas T; Jereczek-Fossa B; Martinelli G; Goldhirsch A; Nolè F
    J Chemother; 2009 Dec; 21(6):687-92. PubMed ID: 20071294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumors.
    Gerl A; Clemm C; Hentrich M; Hartenstein R; Wilmanns W
    Acta Oncol; 1993; 32(5):541-6. PubMed ID: 7692901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary.
    Taylor MH; Depetrillo AD; Turner AR
    Cancer; 1985 Sep; 56(6):1341-9. PubMed ID: 2411377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors.
    Maruyama Y; Sadahira T; Araki M; Mitsui Y; Wada K; Edamura K; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
    Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
    Malogolowkin MH; Krailo M; Marina N; Olson T; Frazier AL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1602-5. PubMed ID: 23703725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
    J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Thomson D; Bishop J; Raghavan D; Tattersall M; Byrne M; Gill G; Harvey V; Snyder R; Dalley D
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1073-7. PubMed ID: 2474445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center.
    Aurilio G; Verri E; Frassoni S; Bagnardi V; Cossu Rocca M; Cullurà D; Milani M; Mascia R; Curigliano G; Orsi F; Jereczek-Fossa BA; Musi G; Omodeo Salè E; De Cobelli O; Nolè F
    Am J Clin Oncol; 2020 Jun; 43(6):381-387. PubMed ID: 32079853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.